Drugs are being invented and manufactured right here in the U.S. by Americans, for Americans. So why doesn’t the industry ...

Conflicts of interest on federal government vaccine panels have declined to “historically low levels” in recent years ...

The Trump administration's ever-changing tariffs and Most Favored Nation drug pricing are part of a blizzard of unclear, ...

The announcement by President Donald Trump's administration of the results of a probe into pharmaceutical imports and new ...

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

The strategy clearly defines the goal of turning Vietnam into a centre for high-value pharmaceutical production in the region, ensuring access to drugs at reasonable costs, improving the capacity to ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

The partnership grants Envirotainer exclusive global rights to offer the innovative Swiss Airtainer as part of its full ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The pharmaceutical industry stands at a critical juncture. To navigate the complexities of sophisticated drug development and manufacturing, a fundamental shift toward AI-powered technologies is ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.

This partnership offers a preview of the future: smarter containers that integrate renewable energy, digital visibility, and lightweight design into one solution.